Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Asthma and COPD are common respiratory diseases that are caused by the interaction of genetic susceptibility with environmental factors. 15302770 2004
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE The application of proteomics to respiratory diseases, such as asthma and COPD, has been limited compared to other fields, like cancer. 22037230 2011
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE COPD and asthma are two respiratory diseases subject to strong environmental influences depending on underlying genetic susceptibility. 22874820 2012
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE The recent advancement in methods identifying microbes has helped implicate the airway microbiome in inflammatory respiratory diseases such as asthma and COPD. 26510171 2016
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE We identified 50 eligible studies.We found that waterpipe tobacco smoking was significantly associated with: respiratory diseases [COPD; odds ratio (OR) = 3.18, 95% confidence interval CI = 1.25, 8.08; bronchitis OR = 2.37, 95% CI = 1.49, 3.77; passive waterpipe smoking and wheeze OR) = 1.97, 95% CI = 1.28, 3.04]; oral cancer OR = 4.17, 95% CI = 2.53, 6.89; lung cancer OR = 2.12, 95% CI = 1.32, 3.42; low birthweight (OR = 2.39, 95% CI = 1.32, 4.32); metabolic syndrome (OR 1.63-1.95, 95% CI = 1.25, 2.45); cardiovascular disease (OR = 1.67, 95% CI = 1.25, 2.24); and mental health (OR 1.30-2.4, 95% CI = 1.20, 2.80). 27075769 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Psychometric properties of the Anxiety Inventory for Respiratory Disease in patients with COPD in China. 28053516 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 GeneticVariation group BEFREE Areas covered: Given the large degree of heterogeneity in COPD, individual variation to treatment is adopted based on its observed phenotype, which in turn overlaps with features of other respiratory disease states such as asthma. 28282995 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 GeneticVariation group BEFREE During a median follow-up of 6·1 years (IQR 4·9), we recorded 800 exacerbations, 2038 cases of pneumonia, and 2789 deaths in the 32 518 individuals at high risk of having COPD, including 152 deaths due to respiratory disease. 28389225 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE This study tested the properties of a Spanish translation of CAPTURE (COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk) with selective use of peak expiratory flow (PEF). 28414029 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Being a high COPD-prone region, programs targeted to address these diseases could help reduce the burden of COPD and respiratory disease-related mortalities in South Asia. 28435242 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE The variability of airway lining fluid pH may explain seasonal incidence of certain non-allergic respiratory diseases such as the catching of a common cold and the increased incidence of COPD exacerbations and exercise-induced bronchoconstriction in cold periods. 28676946 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE COPD is one of the most common respiratory diseases. 28720670 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE This was a cross-sectional study involving clinically stable COPD outpatients with mild hypoxemia (oxygen saturation = 90-94%) at a clinical center specializing in respiratory diseases, located in the city of Goiânia, Brazil. 28746527 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE 12 risk factors with significant differences found between COPD and control groups were listed as follows: male sex (OR = 1.467; 95%CI: 1.097-1.962), smoking (OR = 2.092; 95%CI: 1.707-2.565), low educational level (OR = 1.609; 95%CI: 1.206-2.147), low BMI (OR = 3.831; 95%CI: 2.223-6.603), family history of respiratory disease (OR = 2.068; 95%CI: 1.466-2.918), allergy history (OR = 2.381; 95%CI: 1.385-4.093), respiratory infection during childhood (OR = 2.695; 95%CI: 1.504-4.828), recurrent respiratory infection (OR = 15.015; 95%CI: 4.538-49.684), occupational dust exposure (OR = 1.791; 95%CI: 1.151-2.788), biomass burning (OR = 2.218; 95%CI: 1.308-3.762), poor housing ventilation (OR = 3.993; 95%CI: 1.244-12.820), and living around polluted area (OR = 1.631; 95%CI: 1.202-2.214). 28947023 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE For major physiological signals related to respiratory diseases, such as airflow, heart rate variability, and gait variability, the entropy of a patient with COPD is lower than that of a healthy person. 29066881 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Oxidative stress is implicated in the pathogenesis of respiratory diseases, such as COPD and its comorbidities, asthma, idiopathic pulmonary fibrosis and radiation pneumonitis. 29223018 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Previous investigations in adult smokers from the COPDGene Study have shown that early-life respiratory disease is associated with reduced lung function, COPD, and airway thickening. 29248621 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Patients with COPD and other chronic respiratory diseases are especially vulnerable to viral and bacterial pulmonary infections, which are major causes of exacerbations, hospitalization, disease progression, and mortality in COPD patients. 29255353 2017
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Studies have shown that in utero tobacco exposure, low birth weight, preterm birth, and respiratory diseases, primarily asthma and pneumonia, in early childhood are associated with lung function impairment later in childhood, and by that predispose to subsequent development of COPD, although the causal association between childhood respiratory diseases and COPD has been questioned in one study. 29520136 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE This opens a great opportunity to treat exacerbations of COPD and other chronic respiratory diseases. 29658361 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE The aim of the present investigation was to evaluate the influence of liposome formulation on the ability of vesicles to penetrate a pathological mucus model obtained from COPD affected patients in order to assess the potential of such vesicles for the treatment of chronic respiratory diseases by inhalation. 29678545 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Analyses used data from four waves (2012, 2013, 2014, and 2016) of the Respiratory Disease Specific Programme: cross-sectional surveys of patients with COPD in Germany, Italy, Spain, and the UK. 29805254 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Environmental air pollutants including ozone cause severe lung injury and aggravate respiratory diseases such as asthma and COPD. 30006538 2018
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE The pathobiology of respiratory disease in this subgroup remains poorly defined, but may be due to underlying inflammation that overlaps with COPD or asthma. 30684474 2019
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.100 Biomarker group BEFREE Among the most common respiratory diseases involving polymicrobial infections are cystic fibrosis (CF), non-CF bronchiectasis, COPD and ventilator-associated pneumonia. 30777898 2019